Once homeless, USC Dornsife grad uses grit and determination to pursue his dreams > News > USC Dornsife – USC Dornsife College of Letters, Arts…

Tenacity and a belief in the power of education helped transfer student Nicholas Chapman build a better life for himself. He wants to become a doctor to give others the same chance. [4 min read]

After yet another morning tinged with the smell of whiskey and coffee on his fathers breath, Nicholas Chapman left home to live on the streets. He had finally had enough of the screaming matches, enough of the strict rules.

Chapman grabbed his cell phone. A friend gave him a backpack, $20, a change of clothes and some deodorant. With that, he became one of the thousands in Southern California who have no place to call home.

He was only 17.

But he felt hopeful. He was leaving an unhealthy environment, and he had a vague plan for his future: getting an education.

Eight years later, he is graduating from USC Dornsife College of Letters, Arts and Sciences and plans to become a doctor. His road to get here has been rocky. He just wants to do everything in his power to protect others from similar hardships.

I know how it is to almost fall through the cracks, the fear as if you will lose everything, Chapman said. I decided I didnt want to ever have anyone else have that feeling of losing their life, so conserving lives is my idea.

Early obstacles to a health care career

The 25-year-old graduates this month with a bachelors degree in neuroscience from USC Dornsife. Medical school is up next.

I want to put a mask on and help a person, then take the mask off and also help a person. Advocacy will always be a part of what I do.

Opening a hobby and gaming store in Long Beach helped Nicholas Chapman save enough to buy a car and rent an apartment. (Photo: Courtesy of Nicholas Chapman.)

Its a lesson he learned at a young age from his mother. The two left the United States for her native Brazil when Chapman was 2. She struggled to find work and would tell her young son that education was his best path out of poverty.

Seeing no way forward in Brazil, she encouraged him to return to the U.S. He moved in with his American father in Long Beach, California, at age 14.

Chapman had to learn to read and write in English as a teenager. He hid his struggles from teachers and peers, taking strategic bathroom breaks to avoid reading out loud in class.

Then there was the strained relationship with his dad, who is an alcoholic.

He also talks honestly about when he got caught sneaking out. His dad had grounded him already over another issue, and no end to the punishment was in sight. Chapman decided it was time he left for good.

I stayed in Metro stations. I stayed in homeless shelters. I stayed on friends couches, he said.

Although he had dropped out of high school, Chapman remembered his mothers advice: Get an education. He visited a $1 bookstore, where he pored over economics textbooks for hours. He earned his GED, then enrolled in classes at Long Beach City College.

He did well at first, but lack of sleep and the constant grind of day-to-day survival caught up quickly. His grades slipped. My 4.0 went to a 1.7, just like that, he said.

A mission to study medicine

Then at age 19, stability came in the form of a part-time job at a mom-and-pop hobby store. He sharpened his sales skills and soon became a manager. His grades recovered.

A year later, the store closed. But Chapman had saved some money and made friends with a few regular customers. They launched their own hobby shop, with Chapman as CEO. He soon could afford a car, then a rented room in an apartment.

Although he felt secure in his personal life, his business and economics classes left him uninspired. Then one day, the uncle of a boy he tutored had an epileptic seizure in front of his family and Chapman. Chapman felt shocked and helpless.

I went to that $1 bookstore, grabbed a human biology textbook and read all about the nervous system, he said. Thats when I started falling in love.

He switched his major from economics to psychology. He planned to transfer to the University of California system or USC, with the goal of applying to medical school. But his academic counselor said with the string of poor grades early in his college career, he had no chance.

Nicholas Chapman, 2nd from right, speaks during a panel for incoming transfer students at USC in 2018. (Photo: Eric Lindberg.)

Chapman applied anyway, relying on advice from a USC admissions adviser. He got into three UC schools and USC Dornsife, and he enrolled as a Trojan in Spring 2018.

Giving others a better life through medicine

Now, as he moves into the next phase of his life, with medical school planned for Fall 2021, Chapman took time to look back on his experiences.

My life has been about survival and lost innocence, he said. Working at Childrens Hospital, you see that same innocence diminish when kids realize they are going to die. Its the same innocence you see lost when a transfer student comes in and struggles. I lost that innocence at a young age, being on the streets.

If Chapman achieves his goal of becoming a doctor, he feels he will have gained resources and credibility that he can use to help others. And perhaps sharing his past will give someone the courage or persistence they need to survive.

Theres some kid out there on the streets crying in fear, or getting abused by their parents, or unable to have an education, he said. I want them to see my story and realize that they can push through, that they should conserve life and believe in themselves.

See USC News for more on the story >>

View original post here:
Once homeless, USC Dornsife grad uses grit and determination to pursue his dreams > News > USC Dornsife - USC Dornsife College of Letters, Arts...

Biological to Artificial and Back: How a Core AI Algorithm May Work in the Brain – Singularity Hub

Blame is the main game when it comes to learning.

I know that sounds bizarre, but hear me out. Neural circuits of thousands, if not more, neurons control every single one of your thoughts, reasonings, and behaviors. Take sewing a face mask as an example: somehow, a set of neurons have to link up in specific ways to make sure you dont poke your finger with a sharp needle. Youll fail at the beginning before getting better at protecting your hand while sewing uniform stitches with efficiency.

So the question is, of those neurons that eventually allow you to sew with ease, which onesor which connections between which oneswhere to blame initially for your injuries? Are those ones responsible for your eventual proficiency? How exactly does the brain learn through mistakes?

In a new paper, some of the brightest minds in AIincluding Dr. Geoffrey Hinton, the godfather of deep learning, and folks at DeepMind, the poster child of neuro-AI crossoversargue that ideas behind a core algorithm that drives deep learning also operate within the brain. The algorithm, called backpropagation, was the spark that fired up the current revolution of deep learning as the de facto machine learning behemoth. At its core, backprop is an extremely effective way to assign blame to connections in artificial neural networks and drive better learning outcomes. While theres no solid proof yet that the algorithm also operates in the brain, the authors laid out several ideas that neuroscientists could potentially test out in living brain tissue.

Its a highly controversial idea, partly because it was brought up years ago by AI researchers and refuted by neuroscientists as biologically impossible. Yet recently, the bond between deep learning techniques and neuroscience principles has become increasingly entangled in a constructive feedback circle of ideas. As the authors argue, now may be a good time to revisit the possibility that backpropagationthe heart of deep learningmay also exist in some form in biological brains.

We think that backprop offers a conceptual framework for understanding how the cortex learns, but many mysteries remain with regard to how the brain could approximate it, the authors conclude. If true, it means that somehow our biological brains came up with principles for designing artificial ones that, incredibly, loosely reflect evolutions slow sculpting of our own brains through genes. AI, the product of our brains, will amazingly become a way to understand a core mystery of how we learn.

The neuroscience dogma of learning in the brain is the idea of fire together, wire together. In essence, during learning, neurons will connect to each other through synapses into a network, which slowly refines itself and allows us to learn a tasklike sewing a mask.

But how exactly does that work? A neural network is kind of like a democracy with individuals who are only in contact with their neighbors. Any single neuron only receives input from its upstream partner, and passes along information to its downstream ones. In neuroscience parlance, how strongly these connections are depend on synaptic weightsthink of it as a firmer or looser handshake, or transfer of information. Stronger synaptic weight isnt always better. The main point of learning is to somehow tune the weights of the entire population so that the main outcome is the one we wantthat is, stitching cloths rather than pricking your finger.

Think of it as a voting scenario in which neurons are individual voters who are socially isolated and only in contact with their immediate neighbors. The community, as a whole, knows who they want to vote for. But then an opponent gets electedso the question is, where did things go awry, and how can the network as a whole fix it?

Its obviously not a perfect analogy, but it does illustrate the problem of assigning blame. Neuroscientists can generally agree that neural networks adjust synaptic weights of their neuron members to push the outcome towards something bettera process we call learning. But in order to adjust weights, first the network has to know which connections to adjust.

Enter backpropagation. In deep learning, which consists of multiple layers of artificial neurons connected to each other, the same blame problem exists. Back in 1986, Hinton and his colleagues David Rumelhart and Ronald Willliams found that as information travels across different neural layers, by observing how far the output misses its mark from the desired one, its possible to mathematically compute an error signal. This signal can then be passed back through the neural network layers, with each layer individually receiving a new error signal based on its upper layers. Hence, the name backpropagation.

Its kind of like five people passing each other a basketball in a line, and the last throw misses. The coachin this case, backpropagationwill start from the final player, judge how likely it was his or her problem, and move back down the line to figure out who needs adjustment. In an artificial neural network, adjustment means changing the synaptic weight.

The next step is for the network to compute the same problem again. This time around, the ball goes in. That means whatever adjustments the backprop coach made worked. The network will adopt the new synaptic weights, and the learning cycle continues.

Sound like a logical way of learning? Totally! Backprop, in combination with other algorithms, has made deep learning the dominant technique in facial recognition, language translation, and AIs wins against humans in Go and poker.

The reality is that in deep neural networks, learning by following the gradient of a performance measure works really well, the authors said. Our only other measure of efficient learning is our own brainso is there any chance that the ideas behind backprop also exist in the brain?

30 years ago the answer was a hell no. Many reasons exist, but a main one is that artificial neural networks arent set up the way biological ones are, and the way backprop mathematically works just cant literally translate to what we know about our own brains. For example, backprop requires an error signal to travel along the same paths as the initial feed-forward computationthat is, the information pathway that initially generated the resultbut our brains arent wired that way.

The algorithm also changes synaptic weights through a direct feedback signal. Biological neurons, in general, dont. They can change their connections through more input, or other types of regulationhormones, chemical transmitters, and whatnotbut using the same physical branches and synapses for both forward and feedback signals, while not getting them mixed up, was considered impossible. Add to that the fact that synapses are literally where our brains store data, and the problem becomes even more complicated.

The authors of the new paper have a rather elegant solution. The key is to not take backprop literally, but just adopt its main principles. Here are two as an example.

One, if the brain cant physically use feedback signals to change its synaptic weights, we do know that it uses other mechanisms to change its connections. Rather than an entire biological network using the final outcome to try to change synaptic weights at all levels, the authors argue, the brain could instead alter the ability of neurons to fireand in turn, locally change synaptic weights so that the next time around, you dont prick your finger. It may sound like nit-picking, but the theory changes something rather impossible in the brain to an idea that could work based on what we know about brain computations.

As for the problem of neural branches supporting both feedforward computing signals and feedback adjustment signals, the authors argue that recent findings in neuroscience clearly show that the neurons arent a uniform blob when it comes to computation. Rather, neurons are clearly divided into segments, with each compartment receiving different inputs and computing in slightly different ways. This means its not crazy to hypothesize that neurons can simultaneously support and integrate multiple types of signalsincluding error signalswhile maintaining their memory and computational prowess.

Thats the simple distillation. Many more details are explained in the paper, which makes a good read. For now, the idea of backprop-like signals in the brain remains a conjecture; neuroscientists will have to carry out wet lab experiments to see if empirical data supports the idea. If the theory actually plays out in the brain, however, its another layerperhaps an extremely fundamental onethat links biological learning with AI. It would be a level of convergence previously unimaginable.

Image Credit: Gerd Altmann from Pixabay

Read more:
Biological to Artificial and Back: How a Core AI Algorithm May Work in the Brain - Singularity Hub

Duke Faculty Reexamine Their Roles as Scholars and Mentors in an Uncertain Time – Duke Today

I've had so many people tell me over the last few weeks that they feel like theyre losing their identity, said Sherilynn Black, Associate Vice Provost for Faculty Advancement. The work that they dotheir teaching, research, scholarshipis so much of what makes them who they are.

Responding to the needs of faculty during the coronavirus pandemic, Black and her colleagues in Dukes Office of the Vice Provost for Faculty Advancement are adjusting their programming with topics ranging from virtual student engagement and mentoring, to specific challenges for assistant professors, to an end-of-semester faculty event and summer faculty book club.

On April 15, Black hosted an online workshop, Your Role as a Scholar and Mentor While Navigating the COVID-19 Crisis, for more than 125 people. Panelists were Sally Kornbluth, Provost and Jo Rae Wright University Distinguished Professor; Scott Huettel, Chair and Professor of Psychology and Neuroscience; Adriane Lentz-Smith, Associate Professor of History; and Nimmi Ramanujam, Robert W. Carr, Jr., Distinguished Professor of Biomedical Engineering.

Here are excerpts from the conversation:

Sally Kornbluth, Provost and Jo Rae Wright University Distinguished Professor:

I want to thank the faculty for their flexibility and adaptability in this crisis. The faculty have stepped up and done amazing things. We mounted more than 6,000 online courses [and] we have a very robust COVID-19-related research agenda going on. I think were calling on faculty to do a lot more things than we normally would.

Nimmi Ramanujam, Robert W. Carr, Jr., Distinguished Professor of Biomedical Engineering:

I went through the different stages of grief. In the beginning, I just didnt admit that Id have to have a new normal and a different pace. I feel uncomfortable because Im so used to go, go, go. The idea of actually pausing is incredibly hard, because thats not the norm and so it takes an effort. Theres a tremendous amount of inertia to switch gears, because weve been doing something a certain way for a very long time. I guess I'm recognizing that it does take some time to get to this new place.

Scott Huettel, Chair and Professor of Psychology and Neuroscience:

I think the biggest picture here is to recognize that you should be thinking very hard about what it means to be productive, and focus more on the intrinsic motivators to support your mental health and your own well-being. It doesnt do anyone any good to burn themselves out over the next month, if that is going to have long-term disadvantages for productivity over the next few years. Ive never heard from any administrator anything that prioritizes productivity over mental health and well-being. Put yourself first.

Adriane Lentz-Smith: Associate Professor of History

My entire family is in the house with me and theres a chance an eight-year-old is going to come bursting through the door. I cant write! In this immediate moment when everything is so higgledy-piggledy, I think pulling back, reading and settling into our thoughts have value. And Ive had my students say the same thing to me: Wow, we get much more out of this class when we actually have time to think about what youve assigned to us! For all of the talk of innovation and disruption and new, new, new, actually taking time to read and write and think and be critically engaged with the world around you is still at the heart of what we do and how we thrive.

Sally Kornbluth:

I would urge you as faculty not to create unrealistic expectations about your research agenda. Try to think about how you can keep moving it along, but it's not realistic to think that you're going to spend eight hours a day working on your book.

Nimmi Ramanujam:

Maybe one way to continue to be productive is to be really introspective. This is probably the first time I have lots of time to think. [Ive been] taking a step back and thinking about long-term goals as well as writing proposals that arent rushed. Ive been engaging students in the process of writing proposals and thinking about how to craft something from concept to a document that has some substance to it.

Sally Kornbluth:

Normally, we're all getting ready for a breather at this time of year. How do you think about a breather in the context of the pandemic? I dont think that people can sustain the incredible levels of work and momentum that we've seen over the last weeks, which were under an emergency situation. I encourage faculty to think about this.

Scott Huettel:

It is okay to take a deep breath. If one of my faculty members came to me and said, I can't do this service required for the next month because I have homeschooling on top of stress on top of eldercare, thats normal. Thats actually expected right now. You have a life outside of Duke. Let that be visible to others. Dont send signals that those things are secondary to productivity. Try to use this as a chance to humanize ourselves and be good role models for others in the community.

Nimmi Ramanujam:

I had initiated these undergraduate dinners recently [before social distancing, in person]. I didnt know if students would be interested to do this virtually [but I tried it]. It turned out that not only did the students that would normally show up come, but they had friends of friends of friends. They were asking questions that had nothing to do with their particular [academic] problems. They wanted to know what life is like from other perspectives, and so we ended up having a two-hour conversation. It seemed like very little effort, and it was therapeutic for me.

Adriane Lentz-Smith:

Im opening my classes by saying, Hows everybody doing? Who do you notice thats not here, and does anybody know why? I end by saying, I'm going to be around for five minutes after the lecture, so if you have something that you want to talk to me about, let me know. With graduate students, I said we should decide on a novel that we are all going to read and then convene at some point to talk about itnot a history monograph, and not to perform your intellect, but to just be like, Hey, I read this thing and I have some thoughts or ideas about it.

Scott Huettel:

Think of this next period as a time you get through. Stay as healthy and strong as possible. Draw insights from what youre learning over the next few weeks. As we come out of the immediate problems, the world will stabilize somewhat and then we're going to have opportunities for longer term planning.

Sally Kornbluth:

I think we have to allow ourselves to think really broadly about what we want the university to be 10 years from now. What would that look like if we were not constrained by our current organizational structures, by our current practices, etc.? How do we think about how we distribute resources? How do we think about our students? What kind of advice are we going to give to students who are entering a very different world? I would say there are no sacred cows here. In other words, we have to think broadly about what our priorities are, what we want to preserve going into the futurethings that may fundamentally alter the way we think about delivering our education and think about what really differentiates Duke.

Video footage and a transcript of this conversation will be posted on the website for the Office of the Vice Provost for Faculty Advancement.

See the article here:
Duke Faculty Reexamine Their Roles as Scholars and Mentors in an Uncertain Time - Duke Today

Plant your way to good health this spring – Irvine Standard

Home gardening not only attracts birds, bees and butterflies, it keeps you healthy, according to research by the journal Neuroscience and others.

Twenty years ago, I planted my very first flower garden. Now I have 15. Theyre scattered around my yard, squeezed into every corner and lining my picket fence. Pretty much every day of the year I wander outside and snip whatever is in bloom to bring inside for vases on my kitchen table and bedroom dresser. Sometimes I make bouquets to bring to friends in jelly jars.

I also plant herbs here and there, especially dill and fennel, to attract the butterflies. Bees love my roses. And hummingbirds buzz in and out of an orange bells bush all day long.

But flowers and wildlife arent the only benefits of gardening. Its good for your health. Digging, pruning and planting is a workout, so it will keep you fit. But it also has been shown to lower stress.

According to a study published in the journal Neuroscience, there is evidence that a bacterium found in soil actually stimulates serotonin production, acting as a natural antidepressant. The theory is that just inhaling dirt can actually calm your nerves and boost your mood.

There is even some evidence that gardening might help you live longer.

National Geographic fellow and best-selling author Dan Buettner has identified five places on Earth where folks are living way longer than average (he calls them Blue Zones). One of the common threads: gardening.

So if you have ever had a hankering to dig up a piece of your lawn, do it. May is the perfect month. With the weather warming up, whatever you plop in the earth should flourish.

The key is in the dirt. As you dig (I like to go about a foot deep), throw out any sand or hard clay, and replace it with rich compost from a nursery. You can also find raised-bed kits (no tools required) at Home Depot and Lowes and then fill them with bagged dirt.

Its also important to note how much sun your garden space gets and buy only plants that will succeed in those conditions. A sunny space (at least six hours of sun a day) is easier to tend.

There are dozens of colorful flowers to choose from right now. Some of my favorites include cosmos, coreopsis, verbena, sunflowers, marigolds, coneflowers, zinnias, lavender, every kind of herb (even if you dont eat them, theyre pretty and attract butterflies), and even roses if you have the space. I also put in a few tomato plants every summer. They are easy to grow and should give you fruit by August.

So good luck! Happy digging, pruning and planting.

Lori Basheda is a freelance journalist and full-time home gardener.

More:
Plant your way to good health this spring - Irvine Standard

BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast – GlobeNewswire

NEW HAVEN, Conn., May 05, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Tuesday, May 12, 2020 at 8:30 AM Eastern Time to discuss its first quarter 2020 operating and financial results.

Conference Call & Webcast DetailsDate/Time: Tuesday, May 12, 2020, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915The webcast will be accessible* under "Events" on the News & Media page of the Company's website at http://www.bioxceltherapeutics.com.

ReplayDomestic: 877-660-6853International: 201-612-7415Conference ID: 13703343*Replay available through May 26, 2020

About BioXcel Therapeutics, Inc.:

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit http://www.bioxceltherapeutics.com.

Contact Information:BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com

Investor Relations:John Grazianojgraziano@troutgroup.com1.646.378.2942

Media:Julia Deutschjdeutsch@troutgroup.com1.646.378.2967

Read the original:
BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast - GlobeNewswire

New therapeutic possibilities for treating intellectual disability in Down syndrome – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.May 5 2020

A team of researchers led by Dr. Victoria Puig from the Hospital del Mar Medical Research Institute (IMIM), which also involved the Centre for Genomic Regulation (CRG), has studied the neural basis of intellectual disability in mice with Down syndrome and has discovered that the neural networks of brain circuits relevant to memory and learning are over-activated and that the connectivity of these circuits is poor.

The researchers have also observed that neural activity during sleep is abnormal and probably interferes with memory consolidation.

The study has even identified biomarkers in brain rhythms that can predict memory deficits in the mice which are corrected by chronic treatment with a natural component of green tea, epigallocatechin gallate, which other studies have already shown to improve executive function in adults with Down syndrome.

These results suggest that both hyperactivity of neuronal networks and deficiencies in the connectivity of specific brain circuits are possible dysfunctional mechanisms that contribute to memory deficits in Down syndrome and, therefore, offer new therapeutic possibilities for treating intellectual disability.

Dr. Victoria Puig, Researcher, Integrated Pharmacology and Systems Neuroscience Research Group, IMIM

To date, it had been recognized that epigallocatechin gallate corrects certain alterations at the molecular and cellular levels derived from the trisomy of chromosome 21 that are associated with cognitive deficits in Down syndrome.

However, a dynamic description of the actions of epigallocatechin gallate on neural activity during distinct brain states was lacking. This is, therefore, the first time that anyone has looked at how mouse brain responds to chronic treatment with epigallocatechin gallate at a functional level in trisomy conditions.

The study involved recording neuronal activity simultaneously in two brain regions critical for learning and memory, the prefrontal cortex and the hippocampus, in trisomic and non-trisomic mice during periods of rest while awake, asleep, and during the performance of a simple memory task.

The data was collected before and after one month of treatment with epigallocatechin gallate, and the alterations in the activity of the neuronal networks in the two regions as well as the connectivity of the circuitry correlating with memory capacities were analyzed and found to have been corrected with the green tea extract.

This study provides an in-depth description of the neurophysiological abnormalities present in different brain states in Down syndrome model mice and provides the keys for understanding the cellular mechanisms underlying the improved executive function observed in people with Down syndrome after chronic treatment with epigallocatechin gallate.

Dr. Mara Dierssen, Cellular and Systems Neurobiology Lab, Centre for Genomic Regulation

Dr. Maria Alemany, first author of the paper and also a researcher in the IMIM's Integrated Pharmacology and Neuroscience Systems research group, explains "that the group is evaluating the effects of cognitive stimulation during brain development on the neuronal activity of mice with Down syndrome. This is important for understanding the cellular mechanisms of cognitive stimulation that are normally used in people to improve intellectual disability."

Down syndrome is a genetic alteration produced by the presence of an extra copy of chromosome 21, which is why this syndrome is also known as trisomy 21. It is the main cause of intellectual disability and the most common human genetic alteration. It is estimated that 34,000 people with Down's syndrome live in Spain and that there are a total of six million sufferers worldwide.

This study provides an in-depth description of the neurophysiological abnormalities present in different brain states in Down syndrome model mice and provides the keys for understanding the cellular mechanisms underlying the improved executive function observed in people with Down syndrome after chronic treatment with epigallocatechin gallate.

Dr. Mara Dierssen, Cellular and Systems Neurobiology Lab, Centre for Genomic Regulation

Continued here:
New therapeutic possibilities for treating intellectual disability in Down syndrome - News-Medical.Net

HARMAN enters into a global partnership with Roche to develop a digital therapeutic technology for individuals living with autism – Business Wire

STAMFORD, Conn.--(BUSINESS WIRE)--HARMAN, a wholly-owned subsidiary of Samsung Electronics Co. Ltd., focused on connected technologies for automotive, consumer and enterprise markets, announced today that it has entered into a multi-year, global partnership with Roche to create a digital therapeutic platform for individuals with autism spectrum disorder (ASD). This partnership will combine HARMAN and Samsungs extensive technology and device experience with Roches leadership in neuroscience and developing innovative therapies. HARMAN and Roche will also seek to expand the platform for development of other digital health products across multiple therapeutic areas.

ASD refers to a broad range of social, communication and verbal challenges. According to the Centers for Disease Control, ASD affects both adolescents and adults and an estimated 1 in 59 children in the United States today have ASD. Currently, there are no FDA approved pharmacological therapeutics available to treat ASD.

There is a significant opportunity to apply innovative technologies and enable advanced care for ASD that can positively impact the day-to-day life of individuals and their families who are affected, said David Slump, President, Connected Services, HARMAN. We are honored and excited to collaborate with an esteemed partner like Roche, who drove and originated this partnership. Roche will lead the clinical development, regulatory and commercial strategy, while HARMAN will provide the enabling technology. Together, we are aiming to provide user-centric connected solutions that focus on behavioral therapy to improve social communication for individuals with ASD, increase efficiency, and ultimately boost personalized healthcare access.

We are excited to work with HARMAN to leverage both companys capabilities, in order to develop novel solutions that will support individuals living with ASD, their caregivers and healthcare professionals, said James Sabry, Global Head of Roche Pharma Partnering. We believe that digital behavioral therapy may address some of the challenges of daily life for people living with ASD and potentially expand the treatment modalities.

Roches digital therapeutic platform leverages HARMANs expertise in Consumer, Healthcare, Audio and Visual products and immersive and individualized user experiences by bringing to market consumer technologies tailored to the Personalized Healthcare industry creating a seamless patient journey. In addition, HARMAN will develop the technology by adhering to the Quality Management System defined in accordance to ISO-13485, as well as HIPAA-compliance framework across development, ensuring integrity to protect patients sensitive data and ensuring integrity across clinical workflow of patient care.

For more information visit https://news.harman.com/releases.

Follow HARMAN online:

ABOUT HARMAN

HARMAN (harman.com) designs and engineers connected products and solutions for automakers, consumers, and enterprises worldwide, including connected car systems, audio and visual products, enterprise automation solutions; and services supporting the Internet of Things. With leading brands including AKG, Harman Kardon, Infinity, JBL, Lexicon, Mark Levinson and Revel, HARMAN is admired by audiophiles, musicians and the entertainment venues where they perform around the world. More than 50 million automobiles on the road today are equipped with HARMAN audio and connected car systems. Our software services power billions of mobile devices and systems that are connected, integrated and secure across all platforms, from work and home to car and mobile. HARMAN has a workforce of approximately 30,000 people across the Americas, Europe, and Asia. In 2017, HARMAN became a wholly-owned subsidiary of Samsung Electronics Co., Ltd.

Read more:
HARMAN enters into a global partnership with Roche to develop a digital therapeutic technology for individuals living with autism - Business Wire

Innovation conference Inventures takes an innovative approach through Inventures Unbound – GlobeNewswire

Inventures Unbound announces program highlights:

CALGARY, Alberta, May 06, 2020 (GLOBE NEWSWIRE) -- The third annual Inventures conference, June 3-4, 2020, pivots from in-person to online during the COVID-19 pandemic. The live stream virtual program launches with two half-days and includes more than 30 speakers across six tracks.

Tali Sharot, author of The Optimism Bias and The Influential Mind will be the opening keynote speaker at the launch of Inventures Unbound. Dr. Sharot is a leading expert on decision-making and emotion and her insights have helped organizations induce behavioural change, create effective decision-making policies, and shift hard-held beliefs. Sharots work mixes behavioural economics, psychology and neuroscience.

Dr. Sharots research is fascinating and insightful. Her keynote address will be such a great launch for Inventures as it illuminates why we humans do some of the baffling and amazing things we do, and it will give Inventures Unbound attendees an optimistic boost to start things off with, said Alberta Innovates CEO Laura Kilcrease.

On June 3 and 4, Startup Pitch finalists will present their innovations to a panel of expert judges live in front of a virtual audience. The 18 finalists, chosen from over 200 applicants, will compete across six categories, with the winner in each category taking home a $10,000 cash prize.

The categories and finalists of this years Inventures Startup Pitch Event are:

"Were thrilled that even in a time of global uncertainty, startups are attracted to the value of the Inventures Startup Pitch," said Ms. Kilcrease. "We are looking forward to showcasing the best and brightest entrepreneurs as part of our virtual Inventures Unbound event.

To learn more about Inventures Unbound, visit:nhttps://inventurescanada.com/

For a complete list of Inventures Startup Pitch finalists and alternates, visit: https://inventurescanada.com/pitch-events/startup-pitch-finalists-and-alternates/

For more information about Inventures Unbound, please contact:Dwayne Brunner Manger, Media RelationsAlberta InnovatesDwayne.Brunner@AlbertaInnovates.ca TEL: 587-572-4091

Sponsored by Alberta Innovates, Inventures is Albertas premier innovation event where the best minds from around the world come together in real life and virtually to learn, connect and experience awe-inspiring creative collisions. Inventures Unbound is the ultimate platform to share ideas and engage in a vital, growing community of innovators, investors and service providers.

Read more:
Innovation conference Inventures takes an innovative approach through Inventures Unbound - GlobeNewswire

Addressing the potential impact of coronavirus disease (COVID-19) on Explore Biochemistry Analyzers Market Report 2020-2026 Manufacturers, End Users,…

Analysis of the Global Biochemistry Analyzers Market

The recent market study suggests that the global Biochemistry Analyzers market is expected to grow at a CAGR of ~XX% between 2019 and 2029 and reach a value of ~US$XX by the end of 2029.

The study offers a microscopic view of the various segments and sub-segments of the Biochemistry Analyzers market and accurately represents the data using informative tables, graphs, and figures. The objective of the report is to assist readers to make informed business decisions and improve their position in the global Biochemistry Analyzers market landscape post the COVID-19 pandemic.

Request Sample Report @https://www.mrrse.com/sample/9460?source=atm

Vital data enclosed in the report:

Segmentation Analysis of the Biochemistry Analyzers Market

The Biochemistry Analyzers market study offers a detailed understanding of the consumption, demand, and pricing structure of each product.

The Biochemistry Analyzers market report evaluates how the Biochemistry Analyzers is being utilized by various end-users.

By Region

The report offers valuable insights related to the growth prospects of the Biochemistry Analyzers market in different regions including:

market taxonomy. Macroeconomic factors affecting the global biochemistry analyzers market along with the demand side drivers and supply side drivers are also given in order to give a deep overview of the global biochemistry analyzers market. Besides, restraints impacting the market along with opportunities and trends shaping up the biochemistry analyzers market also given to further add value to the report. The global biochemistry analyzers market analysis and forecast by product type, by end user, by modality, and by region is also given. This section of the report contains valuable information like Basis Point Share (BPS) analysis, Y-o-Y growth projections and market attractiveness analysis to provide in-depth insights into the global biochemistry analyzers market.

Market Segmentation

By Product Type

By Application

By Modality

By End User

By Region

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/9460?source=atm

Questions Related to the Biochemistry Analyzers Market Catered to in the Report:

Buy This Report @ https://www.mrrse.com/checkout/9460?source=atm

Read the original:
Addressing the potential impact of coronavirus disease (COVID-19) on Explore Biochemistry Analyzers Market Report 2020-2026 Manufacturers, End Users,...

Brookhaven biochemist receives award for plant lipid research – News 12 Long Island

A biochemist research associate in the biology department at the U.S. Department of Energys Brookhaven National Laboratory has been awarded the Paul K. Stumpf Award.

Jantana Keereetaweep was given the award for her research on plant lipids.

The award, given every two years, recognizes the contributions of a promising early-career scientist in honor of Stumpf, who was a world leader and pioneer in the study of plant lipid biochemistry.

Keereetaweep will receive a cash award and will present her work via videoconference to the international plant lipid research community this summer.

Dr. Stumpf revolutionized the field of plant lipids. Receiving this award in his name is a great honor, but I believe it is more a reflection of the great work being done at Brookhaven National Laboratory, and especially by our team, headed by Dr. John Shanklin. While we are studying fundamental aspects of plant lipid biosynthesis, our group is also contributing toward the larger effort of developing more efficient means of bioenergy production to address global warming. I would like to express my gratitude to Dr. Shanklin and all my colleagues at Brookhaven Lab for the opportunity to work with them on this important challenge, Keereetaweep said.

Keereetaweep has helped to unravel details of the complicated biochemical pathways that control the synthesis of oil in plants. These studies are essential for understanding fundamental processes necessary for plants survival, and also lay the foundation for engineering plants to make more oil or lipid-based bioproducts such as fuels and raw materials for industrial processes.

Read more:
Brookhaven biochemist receives award for plant lipid research - News 12 Long Island